Fetal Anatomy by Three-Dimensional Ultrasound

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3650 participants

Study Classification

OBSERVATIONAL

Study Start Date

1997-11-26

Study Completion Date

2016-11-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A major goal of perinatal care is to accurately diagnose fetal anomalies prior to birth. This capability allows clinicians to make prudent decisions regarding antepartum care, delivery site, and postnatal therapy. Three-dimensional ultrasound is a recent technology that provides a new way to evaluate the fetus. This technique allows one to scan through a digital ultrasound volume dataset, visualize organs from different perspectives, measure volumes, and render anatomical features through computer processing. However, the accurate characterization of fetal anomalies by this technique must be interpreted in relation to normal fetal anatomy at different stages of pregnancy.

We are continuing to develop an image reference library of fetal anatomy by identifying key diagnostic features by three-dimensional ultrasound. A cross-sectional observational study of up to 1,400 fetuses will catalog a broad spectrum of congenital malformations at various gestational ages. The protocol will include up to 400 examples of normal fetal anatomy by three-dimensional ultrasonography.

All cases will be placed into a digital image database. For each anomaly category, volume reconstructions will be compared to normal anatomy at specific gestational ages. Key diagnostic findings will be documented and correlated with postnatal outcome. We anticipate that our results will permit improved diagnostic interpretation of congenital defects throughout pregnancy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The 3-Dimensional Ultrasound for Fetal Anomaly Scan

NCT00966537

Pregnancy

UNKNOWN

Assesment by Ultrasonography of the Perineal-cephalic Distance

NCT02456753

Ultrasonography, Prenatal

COMPLETED

Implication of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies

NCT05771922

Ultrasound Therapy; Complications Anomaly Central Nervous System Diseases

RECRUITING

The Value of Prenatal Ultrasound in Complicated Twin Pregnancy and Its Correlation With Chromosomal Anomalies

NCT02732717

Complicated Twin Pregnancy

UNKNOWN

Accuracy of 5D LB Ultrasound in Predicting Birth Weight of Preterm Fetuses : A Pilot Study

NCT02401438

Prematurity

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A major goal of perinatal care is to accurately diagnose fetal anomalies prior to birth. This capability allows clinicians to make prudent decisions regarding antepartum care, delivery site, and postnatal therapy. Three-dimensional ultrasound is a recent technology that provides a new way to evaluate the fetus. This technique allows one to scan through a digital ultrasound volume dataset, visualize organs from different perspectives, measure volumes, and render anatomical features through computer processing. However, the accurate characterization of fetal anomalies by this technique must be interpreted in relation to normal fetal anatomy at different stages of pregnancy.

We are continuing to develop an image reference library of fetal anatomy by identifying key diagnostic features by three-dimensional ultrasound. A cross-sectional observational study of up to 7,000 fetuses will catalog a broad spectrum of congenital malformations at various gestational ages. A subset of the fetuses enrolled in this protocol will also be examined by Magnetic Resonance Imaging (MRI) to identify potential advantages and limitations of this imaging modality when compared to 3DUS for the diagnosis of congenital anomalies. The protocol will include up to 400 examples of normal fetal anatomy by three-dimensional ultrasonography.

All cases will be placed into a digital image database. For each anomaly category, volume data will be acquired at specific gestational ages. Key diagnostic features will be documented and correlated with postnatal outcome. Postnatal correlative studies may include ultrasound, MRI, X-ray, computerized tomography (CT), and photography. We anticipate that our results will permit improved diagnostic interpretation of congenital defects throughout pregnancy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preterm Birth Pregnancy Fetal Growth Abnormalities

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant women

Pregnant women aged 18 years and older

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All pregnant subjects will be recruited under informed consent at either Hutzel or William Beaumont Hospitals.

The study population for both arms of this protocol will involve pregnant women greater than or equal to 15 years.

CROSS-SECTIONAL ARM OF PROTOCOL - NORMAL FETUS SUBJECTS:

3DUS STUDIES:

No fetal anomalies suspected by 2DUS.

Excellent visualization of normal fetal anatomy by 2DUS.

Accurate dating criteria by 1st trimester scan and/or menstrual history.

FETAL MRI STUDIES:

Gestational age between 18-42 menstrual weeks.

No known fetal abnormalities.

CROSS-SECTIONAL ARM OF PROTOCOL - ABNORMAL FETUSES:

3DUS STUDIES:

Congenital anomaly suspected by 2DUS.

Accurate dating criteria by 1st trimester scan and/or menstrual history.

FETAL MRI STUDIES:

Gestational age between 18-42 menstrual weeks.

Suspected fetal abnormalities.

POSTMORTEM STUDIES:

Suspected fetal abnormalities by prenatal ultrasound.

Exclusion Criteria

CROSS-SECTIONAL ARM OF PROTOCOL - NORMAL FETUS SUBJECTS:

3DUS STUDIES:

Poor visualization of the fetus due to technical factors (e.g. obesity, surgical scar).

History of noncompliance with prenatal visits with the current or prior pregnancy.

FETAL MRI STUDIES:

Inability of the patient to fit in bore of MRI system.

Metallic implants that would increase risk to patient.

Previous occupational exposure to metal shop.

History of claustrophobia.

CROSS-SECTIONAL ARM OF PROTOCOL - ABNORMAL FETUSES:

3DUS STUDIES:

Poor fetal visualization from technical factors (e.g. obesity or decreased amniotic fluid).

FETAL MRI STUDIES:

Inability of the patient to fit in bore of MRI system.

Metallic implants that would increase risk to patient.

Previous occupational exposure to metal shop.

History of claustrophobia.

POSTMORTEM STUDIES:

Refusal to sign informed consent for postmortem imaging studies.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No